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Abstract
Background: MicroRNAs (miRNAs) mediate posttranscriptional regulation of protein-
coding genes by binding to the 3’ untranslated region of target mRNAs, leading to
translational inhibition, mRNA destabilization or degradation, depending on the
degree of sequence complementarity. In general, a single miRNA concurrently
downregulates hundreds of target mRNAs. Thus, miRNAs play a key role in fine-
tuning of diverse cellular functions, such as development, differentiation, proliferation,
apoptosis and metabolism. However, it remains to be fully elucidated whether a set
of miRNA target genes regulated by an individual miRNA in the whole human
microRNAome generally constitute the biological network of functionally-associated
molecules or simply reflect a random set of functionally-independent genes.
Methods: The complete set of human miRNAs was downloaded from miRBase
Release 16. We explored target genes of individual miRNA by using the Diana-microT
3.0 target prediction program, and selected the genes with the miTG score ≧ 20 as
the set of highly reliable targets. Then, Entrez Gene IDs of miRNA target genes were
uploaded onto KeyMolnet, a tool for analyzing molecular interactions on the
comprehensive knowledgebase by the neighboring network-search algorithm. The
generated network, compared side by side with human canonical networks of the
KeyMolnet library, composed of 430 pathways, 885 diseases, and 208 pathological
events, enabled us to identify the canonical network with the most significant
relevance to the extracted network.
Results: Among 1,223 human miRNAs examined, Diana-microT 3.0 predicted reliable
targets from 273 miRNAs. Among them, KeyMolnet successfully extracted molecular
networks from 232 miRNAs. The most relevant pathway is transcriptional regulation
by transcription factors RB/E2F, the disease is adult T cell lymphoma/leukemia, and
the pathological event is cancer.
Conclusion: The predicted targets derived from approximately 20% of all human
miRNAs constructed biologically meaningful molecular networks, supporting the view
that a set of miRNA targets regulated by a single miRNA generally constitute the
biological network of functionally-associated molecules in human cells.
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MicroRNAs (miRNAs) are a class of endogenous small noncoding RNAs conserved
through the evolution. They mediate posttranscriptional regulation of protein-coding
genes by binding to the 3’ untranslated region (3’UTR) of target mRNAs, leading to
translational inhibition, mRNA destabilization or degradation, depending on the degree
of sequence complementarity [1]. During the biogenesis of miRNAs, the primary miR-
NAs (pri-miRNAs) are transcribed from the intra- and inter-genetic regions of the gen-
o m eb yR N Ap o l y m e r a s eI I ,f o l l o w e db yp r o c e s s i n gb yt h eR N a s eI I Ie n z y m eD r o s h a
into pre-miRNAs. After nuclear export, they are cleaved by the RNase III enzyme
Dicer into mature miRNAs consisting of approximately 22 nucleotides. Finally, a sin-
gle-stranded miRNA is loaded onto the RNA-induced silencing complex (RISC), where
the seed sequence located at positions 2 to 8 from the 5’ end of the miRNA plays a
pivotal role in recognition of the target mRNA [2]. At present, more than one thou-
sand of human miRNAs are registered in miRBase Release 16 http://www.mirbase.org.
The 3’UTR of a single mRNA is often targeted by several different miRNAs, while a
single miRNA concurrently reduces the production of hundreds of target proteins [3].
Consequently, the whole miRNA system (microRNAome) regulate greater than 60% of
all protein-coding genes in a human cell [4]. By targeting multiple transcripts and
affecting expression of numerous proteins, miRNAs play a key role in fine-tuning of
diverse cellular functions, such as development, differentiation, proliferation, apoptosis
and metabolism. Therefore, aberrant regulation of miRNA expression is deeply
involved in pathological events that mediate cancers [5] and neurodegenerative disor-
ders [6].
Recent advances in systems biology have made major breakthroughs by illustrating
the cell-wide map of complex molecular interactions with the aid of the literature-
based knowledgebase of molecular pathways [7]. The logically arranged molecular net-
works construct the whole system characterized by robustness, which maintains the
proper function of the system in the face of genetic and environmental perturbations
[8]. In the scale-free molecular network, targeted disruption of limited numbers of cri-
tical components designated hubs, on which the biologically important molecular
interactions concentrate, efficiently disturbs the whole cellular function by destabilizing
the network [9]. Therefore, the identification of the hub in the molecular network con-
structed by target genes of a particular miRNA helps us to understand biological and
pathological roles of individual miRNAs. Recently, Hsu et al. studied the human micro-
RNA-regulated protein-protein interaction (PPI) network by utilizing the Human Pro-
tein Reference Database (HPRD) and the miRNA target prediction program
TargetScan [10]. They found that an individual miRNA often targets the hub gene of
the PPI network, although they did not attempt to characterize relevant pathways, dis-
eases, and pathological events regulated by miRNA target genes.
At present, the question remains to be fully elucidated whether a set of miRNA tar-
get genes regulated by an individual miRNA in the whole human microRNAome gen-
erally constitute the biological network of functionally-associated molecules or simply
reflect a random set of functionally-independent genes. To address this question, we
attempted to characterize molecular networks of target genes of all human miRNAs by
using KeyMolnet, a bioinformatics tool for analyzing molecular interactions on the
comprehensive knowledgebase.
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MicroRNA Target Prediction
The complete list of 1,223 human miRNAs was downloaded from miRBase Release 16
http://www.mirbase.org. We searched the target genes of individual miRNA on the
Diana-microT 3.0 target prediction program (diana.cslab.ece.ntua.gr/microT), which
was selected because of the highest ratio of correctly predicted targets over other pre-
diction tools [11]. Diana-microT 3.0 calculates the miRNA-targeted gene (miTG) score
that reflects the weighted sum of the scores of all conserved and non-conserved
miRNA recognition elements (MRE) on the 3’UTR of the target mRNA. The miTG
score correlates well with fold changes in suppression of protein expression [11]. To
optimize the parameter of miRNA-target interaction, we considered the target genes
with a cutoff of the miTG score equal to or lar g e rt h a n2 0a st h eh i g h l yr e l i a b l et a r -
gets, because we found that the targets with the miTG score < 20 exhibited the signifi-
cantly lower precision score, an indicator of correctness in predicted interactions [11],
compared with those having the score ≧ 20 (p = 2.78E-08 by Mann-Whitney’s U-test).
Molecular Network Analysis
Ensembl Gene IDs of target genes retrieved by Diana-microT 3.0 were converted into
the corresponding Entrez Gene IDs by using the DAVID Bioinformatics Resources 6.7
program http://david.abcc.ncifcrf.gov[12], where non-annotated IDs were deleted.
Then, Entrez Gene IDs of miRNA target genes were uploaded onto KeyMolnet.
KeyMolnet is a tool for analyzing molecular interactions on the literature-based knowl-
edgebase that contains the contents on 123,000 molecular relationships among human
genes and proteins, small molecules, diseases, pathways and drugs, established by the
Institute of Medicinal Molecular Design (IMMD) (Tokyo, Japan) [13-15]. The core con-
tents are collected from selected review articles and textbooks with the highest reliability,
regularly updated and carefully curated by a team of expert biologists. KeyMolnet contains
a panel of human canonical networks constructed by core contents in the KeyMolnet
library. They represent the gold standard of the networks, composed of 430 pathways, 885
diseases, and 208 pathological events. Detailed information on all the contents is available
from IMMD http://www.immd.co.jp/en/keymolnet/index.html upon request.
We utilized the neighboring network-search algorithm that selects the set of miRNA
target genes as starting points to generate the network around starting points within one
path, composed of all kinds of molecular interactions, including direct activation/inactiva-
tion, transcriptional activation/repression, and the complex formation. By uploading the
list of Entrez Gene IDs onto KeyMolnet, it automatically provides corresponding mole-
cules and a minimum set of intervening molecules as a node on networks. The generated
network was compared side by side with human canonical networks described above. The
algorithm that counts the number of overlapping molecules and/or molecular relations
between the extracted network and the canonical network identifies the canonical network
showing the most statistically significant contribution to the extracted network. This algo-
rithm is essentially based on that of the GO::TermFinder [16]. The significance in the
similarity between the extracted network and the canonical network is scored following
the formula, where O = the number of overlapping molecules and molecular relations for
the pathway or overlapping molecules alone for the disease and the pathological event
between the extracted network and the canonical network, V = the number of molecules
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and/or molecular relations located in the canonical network, T = the number of total
molecules and/or molecular relations of KeyMolnet, currently composed of approximately
15,700 molecules and 123,000 molecular relations, and the × = the sigma variable that
defines coincidence.
Score = −log2 (Score(p)) Score(p) =
Min(C,V) 
x=O
f(x)f (x) = CCx · T−CCV−x/TCV (1)
Results
Molecular Network of MicroRNA Target Genes
Among 1,223 human miRNAs examined, Diana-microT 3.0 predicted the targets from
532 miRNAs (43.5%). Among the 532 miRNAs, 273 miRNAs contained a set of highly
reliable targets showing the miTG score ≧ 20. Among 273 miRNAs having reliable tar-
gets, KeyMolnet successfully extracted molecular networks from 232 miRNAs. They
are comprised of 19% of total human miRNAs (microRNAome). Then, the generated
network was compared side by side with human canonical networks of the KeyMolnet
library, composed of 430 pathways, 885 diseases, and 208 pathological events. We
found that not all 232 miRNAs contained entire categories of canonical networks
because several miRNAs comprised relatively small numbers of targets. See Additional
file 1 for all the information on 232 miRNAs and their target networks. When top
three pathways, diseases, and pathological events were individually totalized, the most
relevant pathway is ‘transcriptional regulation by RB/E2F’ (n = 39; 6.8% of total), fol-
lowed by ‘TGF-beta family signaling pathway’ (n = 32; 5.6%) and ‘transcriptional regu-
lation by POU domain factor’ (n = 24; 4.2%), the most relevant disease is ‘adult T cell
lymphoma/leukemia’ (n = 68; 12.1%), followed by ‘chronic myelogenous leukemia’ (n =
65; 11.5%) and ‘hepatocellular carcinoma’ (n = 51; 9.1%), and the most relevant patho-
logical event is ‘cancer’ (n = 97; 24.7%), followed by ‘adipogenesis’ (n = 46; 11.7%) and
‘metastasis’ (n = 36; 9.2%) (Figure 1 and Additional file 1).
Next, we identified the large-scale miRNA target networks by uploading targets greater
than 100 per individual miRNA onto KeyMolnet (Table 1). Fifty-two miRNAs that
construct such a large-scale miRNA target network include let-7, miR-9, 17, 19, 20, 26,
27, 29, 30, 32, 92, 93, 96, 98, 101, 106b, 124, 137, 147, 153, 218, 372, 429, 495, 506,
519, 520, 603, and their closely-related family members. The targets of these miRNAs
established highly complex molecular networks, in which the pathways of ‘transcrip-
tional regulation by RB/E2F’, ‘transcriptional regulation by Ets-domain family’,a n d
‘transcriptional regulation by p53’,t h ed i s e a s e so f‘chronic myelogenous leukemia’ and
‘viral myocarditis’, and the pathological event of ‘cancer’ were notably accumulated
(Table 1). Importantly, distinct members belonging to the same miRNA family, for
example, five miR-30 family members ranging from miR-30a to miR-30e constructed a
virtually identical molecular network (Table 1).
Biological Implications of MicroRNA Target Networks
As described above, the present observations indicated that a set of miRNA target
genes regulated by an individual miRNA generally constitute the biological network of
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obtain deeper insights into biological implications of miRNA target networks.
The protooncogene c-myb is a key transcription factor for normal development of
hematopoietic cells. A recent study showed that miR-15a targets c-myb, while c-myb
binds to the promoter of miR-15a, providing an autoregulatory feedback loop in
human hematopoietic cells [17]. Consistent with this study, we found ‘transcriptional
regulation by myb’ as the most relevant pathway to the miR-15a target network (the
score = 602; the score p-value = 7.39E-182) (Figure 2 and Additional file 1). These
observations propose a scenario that miR-15a synchronously downregulates both c-
myb itself and downstream genes transcriptionally regulated by c-myb, resulting in
Figure 1 The pathways, diseases, and pathological events relevant to 232 miRNA target networks.
Among 1,223 human miRNAs examined, Diana-microT 3.0 identified the set of reliable targets from 273
miRNAs. Among them, KeyMolnet extracted molecular networks from 232 miRNAs. The generated network
was compared side by side with human canonical networks of the KeyMolnet library, composed of 430
pathways, 885 diseases, and 208 pathological events to identify the canonical network showing the most
statistically significant contribution to the extracted network (see Table S1 for all the information). After top
three pathways, diseases, and pathological events were individually totalized, the cumulated numbers of
top 10 of (a) pathway, (b) disease, and (c) pathological event categories are expressed as a bar graph.
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MicroRNA Number
of
Targets
Molecules
in
KeyMolnet
Networks
Top Pathway Score p-Value Top Disease Score p-Value Top
Pathological
Event
Score p-Value
hsa-let-7a 244 1022 Transcriptional
regulation by
p53
593 2.69E-179 Viral
myocarditis
113 1.21E-34 Cancer 206 1.31E-62
hsa-let-7b 242 1016 Transcriptional
regulation by
p53
594 1.83E-179 Viral
myocarditis
113 9.32E-35 Cancer 206 7.66E-63
hsa-let-7c 243 1020 Transcriptional
regulation by
p53
593 2.49E-179 Viral
myocarditis
113 1.11E-34 Cancer 206 1.10E-62
hsa-let-7d 145 885 Transcriptional
regulation by
RB/E2F
836 2.18E-252 Chronic
myelogenous
leukemia
72 1.95E-22 Cancer 130 9.68E-40
hsa-let-7e 236 1111 Transcriptional
regulation by
p53
575 8.90E-174 Viral
myocarditis
116 1.20E-35 Cancer 175 1.86E-53
hsa-let-7f 244 1022 Transcriptional
regulation by
p53
593 2.69E-179 Viral
myocarditis
113 1.21E-34 Cancer 206 1.31E-62
hsa-let-7g 245 1022 Transcriptional
regulation by
p53
593 2.69E-179 Viral
myocarditis
113 1.21E-34 Cancer 206 1.31E-62
hsa-let-7i 245 1022 Transcriptional
regulation by
p53
593 2.69E-179 Viral
myocarditis
113 1.21E-34 Cancer 206 1.31E-62
hsa-miR-9 352 1115 Transcriptional
regulation by
PPARa
340 5.28E-103 Hepatocellular
carcinoma
72 1.69E-22 Cancer 171 3.50E-52
hsa-miR-
17
195 961 Transcriptional
regulation by
RB/E2F
971 3.27E-293 Chronic
myelogenous
leukemia
92 2.83E-28 Cancer 181 3.58E-55
hsa-miR-
19a
226 1094 Transcriptional
regulation by
RB/E2F
760 2.10E-229 Chronic
myelogenous
leukemia
113 1.26E-34 Cancer 253 7.04E-77
hsa-miR-
19b
225 1094 Transcriptional
regulation by
RB/E2F
760 2.10E-229 Chronic
myelogenous
leukemia
113 1.26E-34 Cancer 253 7.04E-77
hsa-miR-
20a
165 1038 Transcriptional
regulation by
RB/E2F
856 1.64E-258 Chronic
myelogenous
leukemia
87 6.09E-27 Cancer 85 3.33E-26
hsa-miR-
20b
198 981 Transcriptional
regulation by
RB/E2F
962 2.35E-290 Chronic
myelogenous
leukemia
98 3.39E-30 Cancer 183 6.98E-56
hsa-miR-
26a
148 672 Transcriptional
regulation by
RB/E2F
919 1.76E-277 Chronic
myelogenous
leukemia
107 6.15E-33 Cancer 181 3.20E-55
hsa-miR-
26b
148 672 Transcriptional
regulation by
RB/E2F
919 1.76E-277 Chronic
myelogenous
leukemia
107 6.15E-33 Cancer 181 3.20E-55
hsa-miR-
27a
229 1192 Transcriptional
regulation by
CREB
1022 2.23E-308 Chronic
myelogenous
leukemia
95 1.96E-29 Cancer 194 3.05E-59
hsa-miR-
27b
261 1337 Transcriptional
regulation by
CREB
1022 2.23E-308 Chronic
myelogenous
leukemia
94 4.51E-29 Cancer 211 4.11E-64
hsa-miR-
29a
119 543 Transcriptional
regulation by
Ets-domain
family
430 4.36E-130 Glioma 85 3.46E-26 Cancer 139 1.41E-42
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hsa-miR-
29b
118 578 Transcriptional
regulation by
Ets-domain
family
422 1.15E-127 Glioma 82 1.55E-25 Cancer 146 1.44E-44
hsa-miR-
29c
118 543 Transcriptional
regulation by
Ets-domain
family
430 4.36E-130 Glioma 85 3.46E-26 Cancer 139 1.41E-42
hsa-miR-
30a
455 1494 Transcriptional
regulation by
RB/E2F
777 9.43E-235 Chronic
myelogenous
leukemia
86 1.11E-26 Cancer 195 2.39E-59
hsa-miR-
30b
455 1480 Transcriptional
regulation by
RB/E2F
781 1.08E-235 Chronic
myelogenous
leukemia
87 7.01E-27 Cancer 188 1.92E-57
hsa-miR-
30c
454 1495 Transcriptional
regulation by
RB/E2F
778 6.13E-235 Chronic
myelogenous
leukemia
86 1.15E-26 Cancer 191 3.63E-58
hsa-miR-
30d
452 1491 Transcriptional
regulation by
RB/E2F
778 7.28E-235 Chronic
myelogenous
leukemia
86 1.01E-26 Cancer 195 1.96E-59
hsa-miR-
30e
455 1481 Transcriptional
regulation by
RB/E2F
780 1.29E-235 Chronic
myelogenous
leukemia
87 7.25E-27 Cancer 188 2.05E-57
hsa-miR-
32
261 905 Transcriptional
regulation by
RB/E2F
842 2.74E-254 Gastric cancer 80 8.85E-25 Cancer 157 4.19E-48
hsa-miR-
92a
219 642 Transcriptional
regulation by
MEF2
335 1.51E-101 Viral
myocarditis
59 1.62E-18 Epithelial-
mesenchymal
transition
83 7.76E-26
hsa-miR-
92b
258 701 Transcriptional
regulation by
MEF2
328 1.59E-99 Viral
myocarditis
60 1.23E-18 Cancer 94 3.97E-29
hsa-miR-
93
195 958 Transcriptional
regulation by
RB/E2F
972 2.37E-293 Chronic
myelogenous
leukemia
92 2.47E-28 Cancer 181 2.77E-55
hsa-miR-
96
142 688 Transcriptional
regulation by
Ets-domain
family
407 3.42E-123 Viral
myocarditis
36 1.06E-11 Cancer 106 1.37E-32
hsa-miR-
98
162 671 Transcriptional
regulation by
Myb
549 4.73E-166 Viral
myocarditis
85 2.66E-26 Cancer 126 1.42E-38
hsa-miR-
101
188 806 Transcriptional
regulation by
AP-1
492 1.10E-148 Hepatocellular
carcinoma
70 6.40E-22 Cancer 127 4.26E-39
hsa-miR-
106b
164 1028 Transcriptional
regulation by
RB/E2F
854 7.21E-258 Chronic
myelogenous
leukemia
87 5.48E-27 Cancer 85 2.93E-26
hsa-miR-
124
285 1346 Transcriptional
regulation by
RB/E2F
756 3.57E-228 Chronic
myelogenous
leukemia
83 9.34E-26 Cancer 185 1.90E-56
hsa-miR-
137
288 941 Transcriptional
regulation by
MITF family
339 1.19E-102 Adult T cell
lymphoma/
leukemia
66 1.30E-20 Cancer 179 1.00E-54
hsa-miR-
147
199 867 Transcriptional
regulation by
RB/E2F
805 4.06E-243 Chronic
myelogenous
leukemia
113 6.60E-35 Cancer 132 2.57E-40
hsa-miR-
153
154 1019 Transcriptional
regulation by
Myb
507 2.35E-153 Multiple
myeloma
60 6.44E-19 Cancer 174 4.31E-53
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These results suggest a collaborative regulation of gene expression at both transcrip-
tional and posttranscriptional levels that involve coordinated regulation by miRNAs
and transcription factors.
The retinoblastoma protein Rb/E2F pathway acts as a gatekeeper for G1/S transition
in the cell cycle. The Rb/E2F-regulated G1 checkpoint control is often disrupted in
cancer cells. A recent study showed that miR-106b is directly involved in posttranscrip-
tional regulation of E2F1 [18]. E2F1 activates transcription of miR-106b, while miR-
Table 1 The large-scale human microRNA target networks (Continued)
hsa-miR-
218
155 830 Transcriptional
regulation by
AP-1
344 2.28E-104 Hepatocellular
carcinoma
69 1.63E-21 Cancer 136 1.52E-41
hsa-miR-
372
101 562 Transcriptional
regulation by
RB/E2F
1022 2.23E-308 Chronic
myelogenous
leukemia
85 1.90E-26 Cancer 144 2.75E-44
hsa-miR-
429
123 634 Transcriptional
regulation by
RB/E2F
918 2.45E-277 Chronic
myelogenous
leukemia
76 1.71E-23 Cancer 130 5.28E-40
hsa-miR-
495
156 601 Transcriptional
regulation by
Ets-domain
family
431 2.14E-130 Rheumatoid
arthritis
77 5.90E-24 Adipogenesis 79 1.32E-24
hsa-miR-
506
394 1536 Transcriptional
regulation by
Ets-domain
family
317 4.69E-96 Viral
myocarditis
99 1.73E-30 Cancer 172 1.43E-52
hsa-miR-
519a
281 1256 Transcriptional
regulation by
RB/E2F
811 5.32E-245 Chronic
myelogenous
leukemia
106 1.34E-32 Cancer 220 8.03E-67
hsa-miR-
519b-3p
281 1256 Transcriptional
regulation by
RB/E2F
811 5.32E-245 Chronic
myelogenous
leukemia
106 1.34E-32 Cancer 220 8.03E-67
hsa-miR-
519c-3p
281 1256 Transcriptional
regulation by
RB/E2F
811 5.32E-245 Chronic
myelogenous
leukemia
106 1.34E-32 Cancer 220 8.03E-67
hsa-miR-
520a-3p
184 690 Transcriptional
regulation by
RB/E2F
1022 2.23E-308 Chronic
myelogenous
leukemia
94 6.95E-29 Cancer 146 1.12E-44
hsa-miR-
520b
182 690 Transcriptional
regulation by
RB/E2F
1022 2.23E-308 Chronic
myelogenous
leukemia
94 6.95E-29 Cancer 146 1.12E-44
hsa-miR-
520c-3p
182 690 Transcriptional
regulation by
RB/E2F
1022 2.23E-308 Chronic
myelogenous
leukemia
93 9.28E-29 Cancer 145 1.77E-44
hsa-miR-
520d-3p
183 690 Transcriptional
regulation by
RB/E2F
1022 2.23E-308 Chronic
myelogenous
leukemia
94 6.95E-29 Cancer 146 1.12E-44
hsa-miR-
520e
184 690 Transcriptional
regulation by
RB/E2F
1022 2.23E-308 Chronic
myelogenous
leukemia
94 6.95E-29 Cancer 146 1.12E-44
hsa-miR-
603
252 1150 Transcriptional
regulation by
Ets-domain
family
344 3.26E-104 Multiple
myeloma
84 4.36E-26 Cancer 161 4.24E-49
Among 1,223 human miRNAs examined, Diana-microT 3.0 predicted reliable targets from 273 miRNAs. Among them, KeyMolnet extracted molecular
networks from 232 miRNAs. The generated network was compared side by side with human canonical networks of the KeyMolnet library, composed of
430 pathways, 885 diseases, and 208 pathological events. The canonical pathways, diseases, and pathological events with the most statistically significant
contribution to the extracted network are shown. The table contains only the large-scale miRNA target networks generated by importing targets greater
than 100 per individual miRNA into KeyMolnet. See Additional file 1 for all the information on 232 miRNAs and their target networks.
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cer cells [18]. Supporting these findings, we identified ‘transcriptional regulation by
Rb/E2F’ as the most relevant pathway to the miR-106b target network (the score =
854; the score p-value = 7.21E-258) (Figure 3, Table 1 and Additional file 1). The rela-
tionship between miR-106b and Rb/E2F would provide another example of coordinated
regulation of gene expression by miRNAs and transcription factors.
We found ‘transcriptional regulation by p53’ as the most relevant pathway to the tar-
get network of all let-7 family members except for let-7d (Table 1). It is worthy to
note that the tumor suppressor p53 regulates the expression of components of the
miRNA-processing machinery, such as Drosha, DGCR8, Dicer, and TARBP2, all of
w h i c hh a v ep 5 3 - r e p o n s i v ee l e m e n t si nt h e i rpromoters [19]. Furthermore, Dicer and
TARBP2, along with p53, serve as a target of the let-7 family miRNAs, suggesting a
close link between p53 and let-7 in miRNA biogenesis [19]. The expression of let-7
family members was greatly reduced in certain cancer cells [20].
The micropthalmia associated transcription factor (MITF), a basic helix-loop-helix
zipper (bHLH-Zip) transcription factor, acts as not only a master regulator of melano-
cyte differentiation but also an oncogene promoting survival of melanoma. Recent stu-
dies indicate that MITF is a direct target of both miR-137 and miR-148b [21,22].
Again, we identified ‘transcriptional regulation by MITF family’ as the most relevant
pathway to both miR-137 (the score = 339; the score p-value = 1.19E-102) and miR-
Figure 2 Molecular network of miR-15a targets.B yt h e“neighboring” network-search algorithm,
KeyMolnet illustrated a highly complex network of miR-15a targets that has the most statistically significant
relationship with the pathway of ‘transcriptional regulation by myb’. Red nodes represent miR-15a direct
target molecules predicted by Diana-microT 3.0, whereas white nodes exhibit additional nodes extracted
automatically from the core contents of KeyMolnet to establish molecular connections. The molecular
relation is indicated by solid line with arrow (direct binding or activation), solid line with arrow and stop
(direct inactivation), solid line without arrow (complex formation), dash line with arrow (transcriptional
activation), and dash line with arrow and stop (transcriptional repression). The transcription factor myb is
highlighted by a blue circle.
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Additional file 1).
Cellular responsiveness to glucocorticoids (GCs) is regulated by the delicate balance
of the glucocorticoid receptor (GR) protein, GR coactivators and corepressors, GR
splice variants and isoforms, and regulators of GR retrograde transport to the nucleus.
A recent study showed that miR-18a targets the GR protein, and thereby inhibits GR-
mediated biological events in neuronal cells [23]. Consistent with this, we found ‘tran-
scriptional regulation by GR’ as the most relevant pathway to the miR-18a target net-
work (the score = 1022; the score p-value = 2.23E-308) (Additional file 1).
Zinc finger transcription factors ZEB1 and ZEB2 act as a transcriptional repressor of
E-cadherin. A recent study showed that the expression of miR-200b, which targets
both ZEB1 and ZEB2, was downregulated in the cells that undergo TGF-beta-induced
epithelial to mesenchymal transition (EMT), and was losti ni n v a s i v eb r e a s tc a n c e r
cells [24]. We identified ‘transcriptional regulation by ZEB’ as the third-rank significant
pathway (the score = 155; the score p-value = 1.88E-47) and ‘EMT’ as the third-rank
significant pathological event relevant to the miR-200b target network (the score = 61;
the score p-value = 4.15E-19) (Additional file 1).
Discussion
In general, a single miRNA concurrently downregulates hundreds of target mRNAs by
binding to the corresponding 3’UTR of mRNA via either perfect or imperfect sequence
complementarity [3]. Such fuzzy mRNA-miRNA interactions result in the redundancy
Figure 3 Molecular network of miR-106b targets.B yt h e“neighboring” network-search algorithm,
KeyMolnet illustrated a highly complex network of miR-106b targets that has the most statistically
significant relationship with the pathway of ‘transcriptional regulation by Rb/E2F’. Red nodes represent miR-
106b direct target molecules predicted by Diana-microT 3.0, whereas white nodes exhibit additional nodes
extracted automatically from the core contents of KeyMolnet to establish molecular connections. The
molecular relation is indicated by solid line with arrow (direct binding or activation), solid line with arrow
and stop (direct inactivation), solid line without arrow (complex formation), dash line with arrow
(transcriptional activation), and dash line with arrow and stop (transcriptional repression). The transcription
factor E2F is highlighted by a blue circle.
Satoh and Tabunoki BioData Mining 2011, 4:17
http://www.biodatamining.org/content/4/1/17
Page 10 of 13of miRNA-recognized targets. By targeting multiple transcripts and affecting expression
of numerous proteins at one time, miRNAs regulate a wide range of cellular functions,
such as development, differentiation, proliferation, apoptosis and metabolism. There-
fore, we have the question whether a set of miRNA target genes regulated by an indivi-
dual miRNA generally constitute the biological network of functionally-associated
molecules or simply reflect a random set of functionally-independent genes. If the for-
mer is the case, what kind of biological networks does the human microRNAome most
actively regulates?
To address these questions, first we identified the set of credible target genes for all
individual human miRNAs by using the Diana-microT 3.0 program. Then, we investi-
gated miRNA target networks by applying them to KeyMolnet, a bioinformatics tool
for analyzing molecular interactions on the comprehensive knowledgebase. Diana-
microT 3.0 identified highly reliable targets from 273 miRNAs out of 1,223 all human
miRNAs. Previous studies showed that the list of predicted targets for each miRNA
varies among different miRNA target prediction programs armed with distinct algo-
rithms, such as TargetScan 5.1 http://www.targetscan.org, PicTar (pictar.mdc-berlin.
de), miRanda http://www.microrna.org and Diana-microT 3.0 [25]. Therefore, miRNA
target networks are to some extent flexible, depending on the target prediction pro-
gram employed. Among the programs described above, we have chosen Diana-microT
3.0 because of the highest ratio of correctly predicted targets over other prediction
tools and the simplicity of setting a cut-off point for detection of reliable miRNA-tar-
get interactions based on the miTG score [11].
Here we found that highly reliable targets of substantial numbers of human miRNAs
actually constructed biologically meaningful molecular networks. These observations
strongly supported the theoretical view that miRNA target genes regulated by an indi-
vidual miRNA in the whole human microRNAome generally constitute the biological
network of functionally-associated molecules. A recent study showed that interacting
proteins in the human PPI network tend to share restricted miRNA target-site types
than random pairs, being consistent with our observations [26].
We also found that there exists a coordinated regulation of gene expression at the
transcriptional level by transcription factors and at the posttranscriptional level by
miRNAs in miRNA target networks. Recently, Cui et al. investigated the relationship
between miRNA and transcription factors in gene regulation [27]. Importantly, they
found that the genes with more transcription factor-binding sites have a higher prob-
ability of being targeted by miRNAs and have more miRNA-binding sites.
A recent study by miRNA expression profiling of thousands of human tissue samples
revealed that diverse miRNAs constitute a complex network composed of coordinately
regulated miRNA subnetworks in both normal and cancer tissues, and they are often
disorganized in solid tumors and leukemias [28]. During carcinogenesis, various miR-
NAs play a central role, acting as either oncogenes named oncomir or tumor suppres-
sors termed anti-oncomir, by targeting key molecules involved in apoptosis, cell cycle,
cell adhesion and migration, chromosome stability, and DNA repair [5]. Many miRNA
gene loci are clustered in cancer-associated genomic regions [29]. Furthermore,
miRNA expression signatures well discriminate different types of cancers with distinct
clinical prognoses [30]. In the present study, KeyMolnet analysis of miRNA target net-
works showed that the most relevant pathological event is ‘cancer’,w h e nt o pt h r e e
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Page 11 of 13pathological events were overall cumulated. Furthermore, the highly relevant diseases
include ‘adult T cell lymphoma/leukemia’, ‘chronic myelogenous leukemia’,a n d‘hepa-
tocellular carcinoma’. These observations suggest that the human microRNAome plays
a more specialized role in regulation of oncogenesis. Therefore, the miRNA-based ther-
apy directed to targeting multiple cancer-associated pathways simultaneously might
serve as the most effective approach to suppressing the oncogenic potential of a wide
range of cancers.
Conclusion
The reliable targets predicted by Diana microT 3.0 derived from approximately 20% of
all human miRNAs constructed biologically meaningful molecular networks by Key-
Molnet. These observations support the view that miRNA target genes regulated by an
individual miRNA in the whole human microRNAome generally constitute the biologi-
cal network of functionally-associated molecules. In the human miRNA target net-
works, the most relevant pathway is transcriptional regulation by transcription factors
RB/E2F, the disease is adult T cell lymphoma/leukemia, and the pathological event is
cancer. In miRNA target networks, there exists a coordinated regulation of gene
expression at the transcriptional level by transcription factors and at the posttranscrip-
tional level by miRNAs.
Additional material
Additional file 1: KeyMolnet identifies microRNA target networks in 232 human miRNAs. The prediction of
target genes of individual miRNA was performed by Diana-microT 3.0. Entrez Gene IDs of miRNA target genes
were uploaded onto KeyMolnet. The generated network was compared side by side with human canonical
networks composed of 430 pathways, 885 diseases, and 208 pathological events of the KeyMolnet library. Top-
three pathways, diseases, and pathological events with the statistically significant contribution to the extracted
network are shown.
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